Mitomycin-c Application for PRK

Mitomycin-c Application for Photorefractive Keratectomy

To evaluate the safety and efficacy of 5 seconds mitomycin-C (MMC) application during photorefractive keratectomy (PRK) for patients with low myopia.

Inclusion Criteria:

• The inclusion criteria was ablation depth less than 65 µm,
• a stable refractive error for at least 1 year
• corrected distance visual acuity (CDVA) of 0.1 LogMAR or better.

Exclusion Criteria:

• Patients with keratoconus suspect,
• excessive dry eyes,
• impaired wound healing processes,
• lenticular changes,
• corneal dystrophy,
• history of ocular surgery,
• anterior or posterior uveitis,
• glaucoma and retinal diseases were excluded.